According to the latest preliminary research, during Rosh Hashanah in the highly popular Bnei Brak community, nasal sprays may reduce the rate of coronavirus infection.
The risk of coronavirus infection among Traffix users has been reduced by 78%.
As a result, the researchers suggested that Traffix should be used in addition to other preventive measures. No side effects have been reported among users.
The nasal spray manufactured by Nasus Pharma is a nasal powder inhaler that forms a protective layer on the nasal mucosa to prevent viruses from infecting nasal cells. The main ingredient in Traffix, hydroxypropyl methylcellulose, forms a mucosal glue covering the nasal cells, preventing the virus from binding to the receptor.
cnxps.cmd.push(function(){cnxps({playerId:’36af7c51-0caf-4741-9824-2c941fc6c17b’}). render(‘4c4d856e0e6f4e3d808bbc1715e132f6’);});
if(window.location.pathname.indexOf(“656089”)!= -1) {console.log(“hedva connatix”); document.getElementsByClassName(“divConnatix”)[0].style.display = “none”;}
Nasus Pharma is a biopharmaceutical company based in Tel Aviv dedicated to the development of intranasal powder products designed to treat patients in acute and emergency situations. The company focuses on nasal products because they have higher dispersibility and faster nasal absorption.
